These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 28633307)

  • 1. Discussion: The role, position, and function of the FDA-The past, present, and future.
    Fleming TR; Demets DL; McShane LM
    Biostatistics; 2017 Jul; 18(3):417-421. PubMed ID: 28633307
    [No Abstract]   [Full Text] [Related]  

  • 2. Discussion: The FDA is Unprepared for Personalized Medicine.
    Tabarrok A
    Biostatistics; 2017 Jul; 18(3):403-404. PubMed ID: 28633317
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA dependence on drug industry.
    Lawson GW
    J Natl Med Assoc; 2005 Jul; 97(7):1039-40. PubMed ID: 16080677
    [No Abstract]   [Full Text] [Related]  

  • 4. Model-Informed Drug Development: A Regulatory Perspective on Progress.
    Zhu H; Huang SM; Madabushi R; Strauss DG; Wang Y; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):91-93. PubMed ID: 31162631
    [No Abstract]   [Full Text] [Related]  

  • 5. Financial conflicts of interest are related to voting patterns at FDA Advisory Committee meetings.
    Lurie P
    MedGenMed; 2006 Oct; 8(4):22. PubMed ID: 17415305
    [No Abstract]   [Full Text] [Related]  

  • 6. Accelerating evidence gathering and approval of precision medicine therapies: the FDA takes aim at rare mutations.
    Issa AM; Thorogood A; Joly Y; Knoppers BM
    Genet Med; 2019 Mar; 21(3):542-544. PubMed ID: 29988078
    [No Abstract]   [Full Text] [Related]  

  • 7. The voices of patients and families must be heard.
    Schachter SC
    Epilepsy Behav; 2019 May; 94():307. PubMed ID: 30910396
    [No Abstract]   [Full Text] [Related]  

  • 8. Olestra and the FDA.
    Blackburn H
    N Engl J Med; 1996 Apr; 334(15):984-6. PubMed ID: 8596603
    [No Abstract]   [Full Text] [Related]  

  • 9. Financial conflicts of interest and the Food and Drug Administration's Advisory Committees.
    Steinbrook R
    N Engl J Med; 2005 Jul; 353(2):116-8. PubMed ID: 16014880
    [No Abstract]   [Full Text] [Related]  

  • 10. Conflicts of Interest Among Patient and Consumer Representatives to U.S. Food and Drug Administration Drug Advisory Committees.
    Graham SS; Card DJ; Ahn S; Kim SY; Kessler MM; Olson MK
    Ann Intern Med; 2016 Oct; 165(8):606-607. PubMed ID: 27750309
    [No Abstract]   [Full Text] [Related]  

  • 11. The FDA: A tough tonic.
    Wadman M
    Nature; 2009 Nov; 462(7272):406-7. PubMed ID: 19940894
    [No Abstract]   [Full Text] [Related]  

  • 12. Expert Panel Review to Compare FDA and EMA Guidance on Drug Development and Endpoints in Nonalcoholic Steatohepatitis.
    Loomba R; Ratziu V; Harrison SA;
    Gastroenterology; 2022 Mar; 162(3):680-688. PubMed ID: 34822801
    [No Abstract]   [Full Text] [Related]  

  • 13. Former FDA commissioner is fined 90,000 dollars for failing to disclose conflicts of interest.
    Tanne JH
    BMJ; 2007 Mar; 334(7592):492. PubMed ID: 17347206
    [No Abstract]   [Full Text] [Related]  

  • 14. Keeping science on top in drug evaluation.
    Avorn J
    N Engl J Med; 2007 Aug; 357(7):633-5. PubMed ID: 17699813
    [No Abstract]   [Full Text] [Related]  

  • 15. The US Food and Drug Administration's Model-Informed Drug Development Paired Meeting Pilot Program: Early Experience and Impact.
    Madabushi R; Benjamin JM; Grewal R; Pacanowski MA; Strauss DG; Wang Y; Zhu H; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):74-78. PubMed ID: 31081932
    [No Abstract]   [Full Text] [Related]  

  • 16. Politics could hamper FDA reform.
    Fox JL
    Biotechnology (N Y); 1995 Nov; 13(11):1156. PubMed ID: 9678917
    [No Abstract]   [Full Text] [Related]  

  • 17. In need of rehab.
    Nature; 2005 Oct; 437(7060):789-90. PubMed ID: 16208322
    [No Abstract]   [Full Text] [Related]  

  • 18. Vote of confidence for FDA advisory committees, but conflict of interest questions remain.
    Marwick C
    JAMA; 1992 Dec 23-30; 268(24):3417. PubMed ID: 1334160
    [No Abstract]   [Full Text] [Related]  

  • 19. Proposed FDA conflict-of-interest guidelines get lukewarm reception.
    Finkelstein JB
    J Natl Cancer Inst; 2007 May; 99(10):747-8. PubMed ID: 17505067
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings of a Workshop: US Food and Drug Administration-International Society of Pharmacometrics Model-Informed Drug Development in Oncology.
    Bruno R; Jin JY; Maxfield K; Milligan L; Liu C; Wang Y; McKee AE; Zineh I
    Clin Pharmacol Ther; 2019 Jul; 106(1):81-83. PubMed ID: 30951201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.